Anesthesia News

Anesthesia

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Martin K et al. - Both antifibrinolytic drugs bear the risk of adverse outcome depending on the type of cardiac surgery. Administration of aprotinin should be avoided in coronary artery bypass graft and high risk patients, whereas administration of tranexamic acid is not recommended in valve surgery.

Related Articles

Preventing Heart Attacks During Surgery: Drugs Not Foolproof
Ivanhoe, 11/06/09    Relevance Score: 70%

Simplified Management of Hemodialysis-Dependent Patients Undergoing Cardiac Surgery
Annals of Thoracic Surgery, 10/29/09    Relevance Score: 69%

Leucocyte filtration of salvaged blood during cardiac surgery: effect on red blood cell function in concentrated blood compared with diluted blood
European Journal of Cardio-Thoracic Surgery, 10/28/09    Relevance Score: 69%

Adrenal function after induction of cardiac surgery patients with etomidate: A retrospective study
Annales Françaises d'Anesthésie et de Réanimation, 10/22/09    Relevance Score: 69%

The Elderly Patient and Cardiac Surgery - A Mini-Review
Gerontology, 10/13/09    Relevance Score: 69%

Today in Adverse Effects/Events...keeping you current

Postinjection paresthesia with articaine: a case report
Dentistry On-Line, 12/09/09

Unrecognised dural puncture resulting in subdural hygroma and cortical vein thrombosis
Anaesthesia, 12/08/09

Broken Local Anesthetic Needles
The Journal of the American Dental Association , 12/07/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address